Despite mRNA Vaccine Pullback, HHS Awards $48M for Kernal’s mRNA CAR T Program

The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo mRNA-encoded CAR T therapy forward.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top